Liu, W., Kajiyama, H., Shibata, K., Koya, Y., Senga, T., & Kikkawa, F. (2018). Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma. Oncol Lett.

Liu, Wenting, Hiroaki Kajiyama, Kiyosumi Shibata, Yoshihiro Koya, Takeshi Senga, und Fumitaka Kikkawa. "Hematopoietic Lineage Cell-specific Protein 1 Immunoreactivity Indicates an Increased Risk of Poor Overall Survival in Patients With Ovarian Carcinoma." Oncol Lett 2018.

Liu, Wenting, et al. "Hematopoietic Lineage Cell-specific Protein 1 Immunoreactivity Indicates an Increased Risk of Poor Overall Survival in Patients With Ovarian Carcinoma." Oncol Lett 2018.